·Ö×Ó¼äÏ໥×÷ÓÃ

µ°°×¼äÏ໥×÷ÓÃÊÇÉúÃüÏÖÏó·¢ÉúµÄ»ù´¡£¬Ñо¿ÆäÏ໥×÷ÓÿÉÒÔ²ûÃ÷ÉúÎï·´Ó¦µÄ»úÀí£¬½ÒʾÉúÃüÏÖÏóµÄ±¾ÖÊ¡£ËäÈ»ÓÐһЩµ°°×¿ÉÒÔÒÔµ¥ÌåµÄÐÎʽ·¢»Ó×÷Ó㬵«ÊǴ󲿷ֵĵ°°×¶¼ÊÇͨ¹ýµ°°×¼äÏ໥×÷ÓûòÐγɵ°°×¸´ºÏÎïÀ´·¢»Ó×÷ÓõÄ¡£½üÄêÀ´£¬Ñо¿·Ö×ÓÏ໥×÷Óõļ¼Êõ²»¶Ï³öÏÖ¡£½ðÄê»á¡¤(ÖйúÇø)Ìṩµ°°×Ï໥×÷Óüì²â·þÎñ£¬°üÀ¨Fortebio octetÉúÎïĤ²ã¹âѧ¸ÉÉæ¼¼Êõ£¨BLI£©¡¢ÃâÒß¹²³Áµí£¨CO-IP, Co-Immunoprecipitation£©¡¢GST pull-downµÈ£¬Äܹ»ÊµÏÖ¶Ôµ°°×£¬Ð¡·Ö×Ó£¬¿¹Ìå¼°FabƬ¶ÎµÈÏ໥×÷ÓõĶ¨ÐÔ¶¨Á¿·ÖÎö¡£

µ°°×Ï໥×÷Óüì²â·þÎñ

  • ±íÃæµÈÀë×Ó¹²Õñ¼¼Êõ
  • µ°°×»¥×÷¶¨ÐÔ/¶¨Á¿·ÖÎö
  • »¥×÷¡°½ð±ê×¼¡±

  • ÉúÎïĤ²ã¹âѧ¸ÉÉ棨BLI£©
  • µ°°×»¥×÷¶¨ÐÔ/¶¨Á¿·ÖÎö
  • Îȶ¨µ°°×Ï໥×÷ÓÃ

  • ¿¹Ô­¿¹Ìå·´Ó¦ÌØÒìÐÔ
  • µ°°×»¥×÷¶¨ÐÔ·ÖÎö
  • ÌåÄÚÏ໥×÷Óüì²â

  • GST-GSHżÁªÇòÖéÌØÒìÐÔ
  • µ°°×»¥×÷¶¨ÐÔ·ÖÎö
  • ÌåÍâÏ໥×÷Óüì²â

·þÎñÓÅÊÆ

µÂ̩רעµ°°×±í´ï£¬¿É¸ù¾ÝÄúµÄ¼ì²âÒªÇ󣬶¨ÖƵ°°×

µÂ̩רעµ°°×±í´ï£¬¿É¸ù¾ÝÄúµÄ¼ì²âÒªÇ󣬶¨ÖƵ°°×

·á¸»µÄС·Ö×ÓÊý¾Ý¿â×ÊÔ´£¬²éÕÒ/ɸѡÏ໥×÷ÓÃС·Ö×Ó

·á¸»µÄС·Ö×ÓÊý¾Ý¿â×ÊÔ´£¬²éÕÒ/ɸѡÏ໥×÷ÓÃС·Ö×Ó

¿ÉÒÔ¼ì²âÌåÍâ/ÌåÄÚ£¬Èõ/Ç¿£¬Ë²Ê±/Îȶ¨µ°°×Ï໥×÷ÓÃ

¿ÉÒÔ¼ì²âÌåÍâ/ÌåÄÚ£¬Èõ/Ç¿£¬Ë²Ê±/Îȶ¨µ°°×Ï໥×÷ÓÃ

µ°°×Ï໥×÷ÓÃ

ÒÔÏÂÖ÷Òª½éÉÜÁ˵ÂÌ©µ°°×Ï໥×÷Óüì²âµÄÈýÖÖ·½·¨£ºFortebio Octet £¬ÃâÒß¹²³ÁµíCO-IP£¬GST pull-down¡£Ã¿ÖÖ·½·¨ÓÐÆäÊÊÓÃÐÔ£¬¿É¸ù¾ÝʵÑéÒªÇóÑ¡Ôñ¡£

Fortebio octet

Octet? RED96ϵͳÊÇÓÉForteBio¹«Ë¾Éú²úµÄÈ«×Ô¶¯²âÊÔƽ̨£¬¸ÃϵͳÀûÓÃÉúÎïĤ²ã¹âѧ¸ÉÉæ¼¼Êõ£¬Ö»Ðè΢Á¿ÑùÆ·£¬ÎÞÐè´¿»¯£¬¼´¿É¶Ô·Ö×Ó¼äÏ໥×÷ÓýøÐж¨ÐԺͶ¨Á¿µÄ·ÖÎö¡£°üÀ¨¶Ô¶à¸öÒÑÖª»òδ֪µ°°×µÄÏ໥×÷ÓÃÁ¦½øÐÐÅÅÐò£¬¼ø¶¨ÆäÊÇ·ñ´æÔÚµ°°×»¥×÷µÈ¡£Fortebio octet¼ì²âÁéÃô¶È½Ï¸ß²¢Äܹ»²âµÃʵʱµÄ·ÖÎö½á¹û£¬Òò´Ë¿ÉÒÔ¼ì²âÈõÇ׺ÍÁ¦µÄÏ໥×÷ÓúÍ˲ʱÏ໥×÷Óá£

FortebioÏà¹ØÂÛÎÄ

  • A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease
  • H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem

ÃâÒß¹²³Áµí CO-IP

ÃâÒß¹²³ÁµíÊǼì²âµ°°×Ï໥×÷Óõij£Ó÷½·¨¡£ÒÔ¿¹Ô­¿¹Ìå¼äµÄÌØÒìÐÔΪ»ù´¡£¬ÌØÒìÐÔ¿¹Ìå´Óϸ°û³éÌáÎïÖзÖÀëÄ¿µÄµ°°×ºÍÏ໥×÷Óõ°°×µÄ¸´ºÏÎÃâÒß¹²³ÁµíÖ®ºóͨ¹ýWestern blot¼°ÖÊÆ×·¨È·¶¨Ï໥×÷Óõ°°×¡£CO-IP¼È¿ÉÒÔ¼ø¶¨ÒÑÖªÁ½¸öµ°°×ÔÚÌåÄÚµÄÏ໥×÷Óã¬Ò²¿ÉÒÔɸѡδ֪µÄÏ໥×÷Óõ°°×£¬µ«¶¼ÎÞ·¨½øÐÐÏ໥×÷ÓõĶ¨Á¿·ÖÎö£¬Í¬Ê±CO-IPµÄÁéÃô¶È½ÏµÍ£¬¼ì²â²»µ½µ°°×¼äµÄÈõÏ໥×÷ÓúÍ˲ʱÏ໥×÷Óã¬ÇÒʵÑéµÄ¼ÙÑôÐÔÂʽϸߣ¬ÉèÖÃÕýÈ·µÄ¶ÔÕÕÊ®·ÖÖØÒª¡£

CO-IPÏà¹ØÂÛÎÄ

  • Real-time single-molecule co-immunoprecipitation analyses reveal cancer-specific Ras signalling dynamics
  • Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitation

GST pull-down

GSTÈںϵ°°×³Á½µ¼¼Êõ£¨GST pull down£©ÀûÓÃÁËGST¶Ô¹Èë׸ÊëÄżÁªÇòÖéµÄÇ׺ÍÐÔ£¬´Ó·ÇÏ໥×÷Óõ°°×µÄÈÜÒºÖд¿»¯Ï໥×÷Óõ°°×¡£¸Ã·¨¿ÉÒÔ¼ø¶¨ÓëÒÑÖªµ°°×Ï໥×÷ÓõÄδ֪µ°°×£¬Ò²¿É¼ø¶¨Á½¸öÒÑÖªµ°°×¼äÊÇ·ñ´æÔÚÏ໥×÷Óá£GST pull downµÄ³É¹¦Ó¦ÓÃÈ¡¾öÓÚÊÇ·ñÓÐ×ã¹»¶à²¢±£³Ö¿ÉÈÜÐÔµÄGSTÖØ×éÈںϵ°°×£¬½ðÄê»á¡¤(ÖйúÇø)Ìṩ¿ÉÈÜÐÔµ°°×±í´ï·þÎñ£¬²¢³Ðŵ²»³É¹¦ÁãÊÕ·Ñ¡£

pull downÏà¹ØÂÛÎÄ

  • Participation of the extracellular domain in (pro)renin receptor dimerization
  • Analysis of protein partners of the human nucleolar protein SURF6 in HeLa cells by a GST pull-down assay

µ°°×Ï໥×÷ÓÃFAQ

1.ÈçºÎÑ¡Ôñ·Ö×Ó¼äÏ໥×÷Óüì²â·½·¨£¿

¼¼Êõ SPR BLI CO-IP GST pull-down
Ô­Àí ±íÃæµÈÀë×Ó¹²Õñ¼¼Êõ ÉúÎïĤ²ã¹âѧ¸ÉÉæ¼¼Êõ ¿¹Ô­¿¹Ìå·´Ó¦µÄÌØÒìÐÔ GST¶Ô¹Èë׸ÊëÄżÁªÇòÖéµÄÌØÒìÐÔ
ɸѡ»¥×÷µ°°× ¡Ì X ¡Ì ¡Ì
ÑéÖ¤»¥×÷µ°°× ¡Ì ¡Ì ¡Ì ¡Ì
˲ʱÏ໥×÷Óà ¡Ì X X X
ÈõÇ׺ÍÁ¦¼ì²â ¡Ì ¡Ì X X
¶¨Á¿·ÖÎö ¡Ì ¡Ì X X
¶¨ÐÔ·ÖÎö ¡Ì ¡Ì ¡Ì ¡Ì

2.½ðÄê»á¡¤(ÖйúÇø)µÄ·Ö×Ó¼äÏ໥×÷Óüì²â·þÎñÓÅÊÆ£¿

  • SPR¼¼Êõ×÷Ϊ»¥×÷¼¼ÊõµÄ¡°½ð±ê×¼¡°£¬¿ÉÒÔ±£Ö¤²âÊÔ½á¹ûµÄ׼ȷÐÔ£»²âÊÔ¹ý³ÌÖÐÎÞÐè¶ÔÑùÆ·½øÐжîÍâ±ê¼Ç£»¿É½øÐж¯Á¦Ñ§ºÍÎÈ̬·ÖÎö£¬ÊµÊ±»ñµÃ·Ö×ÓÖ®¼äµÄ½áºÏºÍ½âÀëËÙÂÊ£»
  • BLI¼¼ÊõÁéÃô¶È¸ß£¬²âµÃÈõÇ׺ÍÁ¦Ï໥×÷Óã»ÊµÊ±¼à¿Ø£¬²âµÃ˲ʱÏ໥×÷Óã»ÊµÑé¿É»ñµÃÏêϸÊý¾Ý£¬¿É¶Ôµ°°×Ï໥×÷ÓýøÐж¨Á¿·ÖÎö£¬ºÍ²»Í¬µ°°×¼äµÄÏ໥×÷ÓÃÁ¦½øÐÐÅÅÐò£»
  • CO-IP£¬GST pull downÓÃÓÚ¶Ô·Ö×Ó¼äÏ໥×÷Óö¨ÐÔ·ÖÎö£¬°üÀ¨¼ø¶¨ÒÑÖªÁ½¸öµ°°×ÊÇ·ñ´æÔÚÏ໥×÷Óã¬É¸Ñ¡ÓëÒÑÖªµ°°×»¥×÷µÄδ֪µ°°×£»
  • С·Ö×Ó¿â×ÊÔ´£º×¨Òµ¼¼ÊõÈËÔ±²éÕÒ×ÊÔ´£¬ÔÚÄú²»È·¶¨Ï໥×÷ÓÃС·Ö×ÓµÄÇé¿öÏ£¬½ðÄê»á¡¤(jinnian½ðÄê»á)¿ÉÒÔÔÚÊý¾Ý¿âÖнøÐвéÕÒɸѡ¡£

µ°°×Ï໥×÷Óüì²â·½·¨×ÛÊö

Ëæ×ÅÉúÃü¿ÆѧÑо¿µÄ²»¶Ï·¢Õ¹£¬ÈËÃÇÖð½¥Òâʶµ½»ùÒò×éÐÅÏ¢ÒѾ­²»ÄÜÍêÈ«½âÊͺÍÔ¤²â¸÷ÖÖÉúÃü¹ý³Ì¼°ÏÖÏ󣬶øµ°°×ÖÊ×÷Ϊϸ°û»îÐԺ͹¦ÄܵÄÖ´ÐÐÕߣ¬Ô½À´Ô½Êܵ½ÈËÃǵĹØ×¢¡£È»¶ø£¬µ°°×Öʹ¦Äܵķ¢»Ó²»ÊÇƾ½èµ¥¸öµ°°×ÖʶÀÁ¢Ö´ÐУ¬¶øÊÇÒÀ¿¿µ°°×ÖÊÓëµ°°×ÖÊÏ໥×÷ÓÃ(protein-protein interaction, PPI)Ö´ÐÐÆ书ÄÜ¡£Òò´Ë£¬µ°°×ÖÊÏ໥×÷ÓóöÏÖÒì³£½«»áÓ°Ïìϸ°û»îÐԺ͹¦Äܵķ¢»Ó£¬´Ó¶øÒý·¢Ðí¶à¼²²¡£¬ÈçÉñ¾­ÍËÐÐÐÔ¼²²¡¡¢°©Ö¢µÈ¡£ÒÖÖÆÕâЩÒì³£µÄµ°°×ÖÊÏ໥×÷ÓöÔÁÙ´²ÖÎÁƾßÓÐÖØÒªÒâÒå¡£

¼ì²â·¶Î§ ¼ì²â·½·¨
In vivoÌåÄÚ ÃâÒß¹²³Áµí£¨Co-IP£©
Ó«¹â¹²ÕñÄÜÁ¿×ªÒÆ£¨FRET£©
ÁÚ½üµ°°×±ê¼ÇBioID
½Íĸ˫ÔÓ½»£¨Yeast Two-hybrid£©
In vitroÌåÍâ Èںϵ°°×³Á½µ¼¼Êõ£¨GSTPull down£©
Far-Western
±íÃæµÈÀë×Ó¹²Õñ£¨SPR£©
TAP´®ÁªÇ׺ʹ¿»¯¼¼Êõ
µ°°×ÖÊоƬ¼¼Êõ£¨Protein microarrays£©

ÃâÒß¹²³Áµí

¸Ã¼¼ÊõÊÇÑо¿µ°°×Ï໥×÷Óõľ­µä¼¼Êõ£¬Ó¦Óù㷺ÇÒ¿ÉÐŶȽϸߡ£ËüÀûÓÃÌØÒìÐÔ¿¹Ìå´Óϸ°û³éÌáÎïÖзÖÀëÄ¿µÄµ°°×ºÍÏ໥×÷Óõ°°×µÄ¸´ºÏÎ֮ºóͨ¹ýWestern blot¼°ÖÊÆ×·¨È·¶¨Ï໥×÷Óõ°°×¡£Èç¹ûÔڷDZäÐÔµÄÌõ¼þÏÂÁѽâϸ°û£¬µ°°×¼äÏ໥×÷ÓÿÉÒÔ±£³Ö£¬ËùÒԾͿÉÀûÓÃÃâÒß¹²³Áµí·½·¨ÕÒ³öÏ໥×÷Óõĵ°°×ÖÊ¡£ÃâÒß¹²³Áµí¼È¿ÉÒÔÓÃÓÚ¼ìÑéÒÑÖªµÄÁ½¸öµ°°×ÖÊÔÚÌåÄÚµÄÏ໥×÷Óã¬Ò²¿ÉÒÔÕÒ³öδ֪µÄµ°°×Ï໥×÷Óá£

Á¢¼´Ñ¯¼Û
  • ÐÕÃû

  • µ¥Î»

  • µç»°

  • ×ÉѯÏîÄ¿

  • ÑéÖ¤Âë

  • ÁôÑÔ:

  • ¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿
  • ¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿